125 related articles for article (PubMed ID: 31049070)
21. BRM270 targets cancer stem cells and augments chemo-sensitivity in cancer.
Chandimali N; Koh H; Kim J; Lee J; Park YH; Sun HN; Kwon T
Oncol Lett; 2020 Oct; 20(4):103. PubMed ID: 32831922
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma.
Tanaka T; Li TS; Urata Y; Goto S; Ono Y; Kawakatsu M; Matsushima H; Hirabaru M; Adachi T; Kitasato A; Takatsuki M; Kuroki T; Eguchi S
J Gastroenterol; 2015 Sep; 50(9):975-83. PubMed ID: 25542265
[TBL] [Abstract][Full Text] [Related]
23. Fraction B From Catfish Epidermal Secretions Kills Pancreatic Cancer Cells, Inhibits CD44 Expression and Stemness, and Alters Cancer Cell Metabolism.
Al-Hassan JM; Wei D; Chakraborty S; Conway T; Rhea P; Wei B; Tran M; Gagea M; Afzal M; Oommen S; Nair D; Paul BM; Yang P
Front Pharmacol; 2021; 12():659590. PubMed ID: 34349642
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of the antiproliferative efficacy of BRM270 phytocomposite nanoparticles against human hepatoma cancer cell lines.
Gera M; Kim N; Ghosh M; Sharma N; Huynh DL; Chandimali N; Koh H; Zhang JJ; Kang TY; Park YH; Kwon T; Jeong DK
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():166-176. PubMed ID: 30678901
[TBL] [Abstract][Full Text] [Related]
25. HMGN5 promotes proliferation and invasion via the activation of Wnt/β-catenin signaling pathway in pancreatic ductal adenocarcinoma.
Zhao J; Wang Y; Wu X
Oncol Lett; 2018 Sep; 16(3):4013-4019. PubMed ID: 30128022
[TBL] [Abstract][Full Text] [Related]
26. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
[TBL] [Abstract][Full Text] [Related]
27. Hedgehog signaling and therapeutics in pancreatic cancer.
Kelleher FC
Carcinogenesis; 2011 Apr; 32(4):445-51. PubMed ID: 21186299
[TBL] [Abstract][Full Text] [Related]
28. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
29. Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1.
Yu D; Shin HS; Lee YS; Lee D; Kim S; Lee YC
Oncol Rep; 2014 Feb; 31(2):673-8. PubMed ID: 24297371
[TBL] [Abstract][Full Text] [Related]
30. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P
Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433
[TBL] [Abstract][Full Text] [Related]
31. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
32. Sedum sarmentosum Bunge extract induces apoptosis and inhibits proliferation in pancreatic cancer cells via the hedgehog signaling pathway.
Bai Y; Chen B; Hong W; Liang Y; Zhou M; Zhou L
Oncol Rep; 2016 May; 35(5):2775-84. PubMed ID: 26987050
[TBL] [Abstract][Full Text] [Related]
33. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
34. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
35. Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.
Poruk KE; Blackford AL; Weiss MJ; Cameron JL; He J; Goggins M; Rasheed ZA; Wolfgang CL; Wood LD
Clin Cancer Res; 2017 Jun; 23(11):2681-2690. PubMed ID: 27789528
[No Abstract] [Full Text] [Related]
36. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
[TBL] [Abstract][Full Text] [Related]
37. Pen2/ErbB4 signaling regulates stemness of pancreatic ductal carcinoma.
Zhu Z; Ding D; Hu H; He T
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(7):167316. PubMed ID: 38901650
[TBL] [Abstract][Full Text] [Related]
38. Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway.
Subramani R; Gonzalez E; Nandy SB; Arumugam A; Camacho F; Medel J; Alabi D; Lakshmanaswamy R
Oncotarget; 2017 Feb; 8(7):10891-10904. PubMed ID: 26988754
[TBL] [Abstract][Full Text] [Related]
39. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
40. δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis.
Husain K; Centeno BA; Coppola D; Trevino J; Sebti SM; Malafa MP
Oncotarget; 2017 May; 8(19):31554-31567. PubMed ID: 28404939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]